CRH Plc Q4 2023 Financial Report – Revenues Decline, Profits and EPS Down

By Bobby Samwell • Thursday, April 11 10:28 • Permanent Link

CRH plc, a leading provider of building materials solutions, has released its quarterly financial information under U.S. GAAP for the financial year ended December 31, 2023. Let's dive into the specific figures and see how the company has performed.

For the three months ended December 31, 2023, CRH reported total revenues of $8,685 million, representing a decrease from the previous quarter's total revenues of $10,128 million. The cost of revenues for the same period also decreased to $5,734 million from $6,365 million in the previous quarter.

The gross profit for the quarter stood at $2,951 million, down from $3,763 million in the previous quarter. Similarly, the operating income decreased to $783 million from $1,788 million in the previous quarter.

Moving on to the earnings per share (EPS), the company reported a basic EPS of $0.99 and a diluted EPS of $0.99 for the quarter ended December 31, 2023, compared to a basic EPS of $1.81 and a diluted EPS of $1.80 in the previous quarter.

Looking at the segment information, the Americas Materials Solutions segment reported an adjusted EBITDA of $875 million for the quarter, down from $1,284 million in the previous quarter. Similarly, the Europe Building Solutions segment reported an adjusted EBITDA of $280 million, a decrease from $692 million in the previous quarter.

In terms of cash flows from operating activities, CRH reported a net cash provided by operating activities of $5,017 million for the year ended December 31, 2023, compared to $2,594 million for the nine months ended September 30, 2023.

As a result of these announcements, the company's shares have moved -0.6% on the market, and are now trading at a price of $82.97. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.